Next 10 |
home / stock / frx:cc / frx:cc news
A look at the top 10 most actives in Canada Enbridge Inc. (ENB) fell 2.4% to $50.45 on volume of 27,490,266 shares BlackBerry Limited (BB) rose 11.3% to $4.74 on volume of 23,663,931 shares Suncor Energy Inc. (SU) fell 1.3% to $53.5 on volume of 16,590,998 shares Cenovus Energy Inc. (CV...
A look at the top 10 most actives in Canada Enbridge Inc. (ENB) fell 2.5% to $50.4 on volume of 8,817,206 shares Therma Bright Inc. (THRM) rose 0.0% to $0.01 on volume of 6,785,050 shares BlackBerry Limited (BB) rose 14.3% to $4.87 on volume of 5,135,771 shares iShares S&P/TSX 60 In...
~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction ~ ~ Executed Exclusive Licensing Agreement with Norgine to Commercialize PEDMARQSI™ in Europe, Australia, ...
Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial...
Bridgemarq Real Estate Services Inc. Restricted Voting Shares (BRE:CA) is expected to report for quarter end 2023-12-31 Avivagen Inc. (VIV:CA) is expected to report for quarter end 2024-01-31 Andean Precious Metals Corp. (APM:CA) is expected to report $0 for Q4 2023 Aimia Inc. (AIM:CA...
~ Achieved PEDMARK ® Full-Year 2023 Net Product Sales of $21.3 Million, Including $9.7 Million in Net Product Sales in the Fourth Quarter of 2023 ~ ~ Entered Into Exclusive Licensing Agreement to Commercialize PEDMARQSI™ in Europe, Australia and New Zealand for Appro...
RESEARCH TRIANGLE PARK, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its full year and fourth quarter 2023 financial results before the opening of t...
Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI ® , the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with localized, non-metastatic soli...
~ Fourth Quarter 2023 Net Revenues of Approximately $9.2 to $9.7 Million ~ ~ Company Expects to Report 2023 Fourth Quarter and Audited Full-Year Results on or about March 26, 2024 ~ RESEARCH TRIANGLE PARK, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NA...
News, Short Squeeze, Breakout and More Instantly...
Fennec Pharmaceuticals Inc. Company Name:
FRX:CC Stock Symbol:
TSXC Market:
A look at the top 10 most actives in Canada Enbridge Inc. (ENB) fell 2.4% to $50.45 on volume of 27,490,266 shares BlackBerry Limited (BB) rose 11.3% to $4.74 on volume of 23,663,931 shares Suncor Energy Inc. (SU) fell 1.3% to $53.5 on volume of 16,590,998 shares Cenovus Energy Inc. (CV...
A look at the top 10 most actives in Canada Enbridge Inc. (ENB) fell 2.5% to $50.4 on volume of 8,817,206 shares Therma Bright Inc. (THRM) rose 0.0% to $0.01 on volume of 6,785,050 shares BlackBerry Limited (BB) rose 14.3% to $4.87 on volume of 5,135,771 shares iShares S&P/TSX 60 In...
~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction ~ ~ Executed Exclusive Licensing Agreement with Norgine to Commercialize PEDMARQSI™ in Europe, Australia, ...